AstraZeneca | AZN - Despesas De Vendas E Administração

Preço das Ações
13,580.00
Mudança Diária
250.00 1.88%
Mensal
-9.21%
Anual
29.28%
Q2 Previsão
13,283.65




Despesas De Vendas E Administração Alterar Data
AbbVie USD 3.58B 316M 2026-03
Alcon AG USD 901M 36M 2025-12
Amgen USD 1.58B 354M 2026-03
argenx SE USD 429.62M 93.32M 2025-12
AstraZeneca USD 5.06B 455M 2026-03
Autolus Therapeutics Ltd USD 35.79M 1.68M 2025-12
Bayer EUR 4.05B 647M 2025-12
Biogen USD 554.3M 128.2M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Eli Lilly USD 2.93B 198M 2026-03
Fresenius EUR 819M 143M 2025-12
Fresenius Medical Care EUR 749M 36M 2026-03
Galapagos EUR 44.42M 9.87M 2025-12
Genmab DKK 208M 60M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.12B 558M 2026-03
GRIFOLS EUR 275.3M 9.7M 2025-12
Haleon GBP 1.08B 11M 2025-06
Hikma Pharmaceutical USD 288M 149M 2025-12
Merck EUR 1.6B 136M 2025-12
Merck USD 2.67B 180M 2026-03
Novartis USD 3.14B 296M 2026-03
Orion EUR 91.9M 18.8M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Philips EUR 1.31B 127M 2025-12
Recordati EUR 171.38M 15.6M 2025-09
Regeneron Pharmaceuticals USD 647.7M 127.3M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
UCB EUR 1.47B 193M 2025-12